Haytham A Wali

Pharmacy — King Faisal University, Saudi Arabia

LeadR Profile

Haytham A Wali King Faisal University Saudi Arabia
106 ScienceLeadR Reputation 106
Network Map

Pharmacy

Subspecialties: Infectiology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2012 - 2026

Source: PubMed

King Faisal University

could not re-read experiences after save", error); return null; } if (persistedEntries === null) { return null; } if (persistedEntries.length === 0 && sent.some((entry) => entry.isvisible !== false)) { console.warn(" re-read after save came back empty, keeping the edited entries"); return null; } this.state.current.experience = persistedEntries; const expected = this.yearsSignature(sent); const received = this.yearsSignature(persistedEntries.map((entry) => ({ isvisible: entry.isvisible, topresent: entry.topresent, year_start: entry.startperiod, year_stop: entry.endperiod }))); if (expected !== received) { console.error(" saved experiences were not persisted as sent", { sent: expected, received: received }); return false; } return true; }, async fetchExperiences() { const response = await $.ajax({ url: ajaxLoadUserData, type: "POST", data: { security: ajaxDataLoadUserData.security, data_to_load: "OrganizationHisto", } }); const parsedData = JSON.parse(response); if (parsedData.loaded === false || !parsedData.user_data || !Array.isArray(parsedData.user_data)) { return null; } return parsedData.user_data.map((value, index) => ({ company: value["name"], url: "", position: (value.hasOwnProperty("position") ? ( value["position"] ) : ( "" ) ), startperiod: value["year_start"], endperiod: value["year_stop"], topresent: (value.hasOwnProperty("topresent") ? ( value["topresent"] ) : ( false ) ), orgid: value["orgid"], isvisible: (value.hasOwnProperty("isvisible") ? ( value["isvisible"] ) : ( true ) ), description: "", tags: [], isOpen: false, ismain: (value.hasOwnProperty("ismain") ? ( value["ismain"] ) : ( (index === 0) ? true : false ) ) })); }, async loadDataOnMount() { this.loading = true; try { const experiences = await this.fetchExperiences(); this.loadFailed = experiences === null; if (experiences !== null) { this.state.current.experience = experiences; } } catch (error) { console.warn(" could not load experiences", error); this.loadFailed = true; } this.loading = false; } }, computed: { experience: { get() { return this.state.current.experience }, }, }, async mounted() { await this.loadDataOnMount() }, } }; })

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 29

Citations

Citations: 105 1st author: 12 Last author: 5 Unique author: 1


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Characteristics and outcomes of patients treated with tigecycline for MDR gram-negative infections: a retrospective cohort study.
mortality, genes, mdr, urinary tract, cohort studies, cell biology, urinary tract infections, therapeutics, tigecycline, infections
Front Cell Infect Microbiol20260
Risk Factors and Outcomes for Invasive Infection Among Patients Colonized with Candidozyma auris: A Case-Control Study.
comorbidity, mortality, case-control studies, hospital mortality, mycoses, risk factors, infections
Antibiotics (Basel)20250
Successful treatment of methicillin-resistant Staphylococcus aureus osteomyelitis and persistent bacteremia using adjunctive ceftaroline fosamil to vancomycin: A case report.
diabetes mellitus, bacteremia, skin, osteomyelitis, methicillin-resistant staphylococcus aureus, staphylococcus, heart diseases, heart, vancomycin, heart failure, systolic, cephalosporins, staphylococcus aureus, therapeutics, methicillin, diabetes mellitus, type 2
IDCases20250
Recurrence, Readmission, and Key Mortality Predictors in Patients with Carbapenem-Resistant Enterobacterales Infections.
diabetes mellitus, mortality, pneumonia, risk factors, therapeutics, carbapenems, infections
Diagnostics (Basel)20250
Effectiveness of Carbapenem-Sparing Antibiotics Versus Carbapenems for Treating Non-Bacteremic Extended-Spectrum Beta-Lactamase-Producing Enterobacterales Infections.
mortality, therapeutics, beta-lactamases, carbapenems, infections
Infect Drug Resist20250

LeadR Networks

Main global connection map